Pages that link to "Q37895027"

The following pages link to Cancer of unknown primary: progress in the search for improved and rapid diagnosis leading toward superior patient outcomes. (Q37895027):

Displaying 36 items.

• Cancers of unknown primary origin: current perspectives and future therapeutic strategies (Q21245496) (← links)
• Cancer of unknown primary sites: what radiologists need to know and what oncologists want to know (Q26823666) (← links)
• Carcinoma of unknown primary with gastrointestinal profile: immunohistochemistry and survival data for this favorable subset. (Q30652409) (← links)
• Comparison of survival of patients with metastases from known versus unknown primaries: survival in metastatic cancer (Q34565458) (← links)
• Novel microRNA-based assay demonstrates 92% agreement with diagnosis based on clinicopathologic and management data in a cohort of patients with carcinoma of unknown primary (Q34768554) (← links)
• A second-generation microRNA-based assay for diagnosing tumor tissue origin (Q36051505) (← links)
• Hepatocellular carcinoma presenting as thoracic spinal canal metastasis with no clinical primary foci: A report of a rare case and review of the literature (Q36085978) (← links)
• Metastatic Adenocarcinoma of Unknown Origin Presenting as Small Bowel Perforation: A Case Report and Literature Review (Q36103240) (← links)
• Possibility of molecular targeting therapy for the treatment of cancer of unknown primary origin by analysis of intracellular signaling molecules (Q36224208) (← links)
• Age-Dependent Metastatic Spread and Survival: Cancer of Unknown Primary as a Model (Q36724760) (← links)
• Cancer of unknown primary: a population-based analysis of temporal change and socioeconomic disparities. (Q37185727) (← links)
• Germline genetics of cancer of unknown primary (CUP) and its specific subtypes (Q37225491) (← links)
• A case study of an integrative genomic and experimental therapeutic approach for rare tumors: identification of vulnerabilities in a pediatric poorly differentiated carcinoma. (Q37383599) (← links)
• A multicenter study directly comparing the diagnostic accuracy of gene expression profiling and immunohistochemistry for primary site identification in metastatic tumors. (Q37607002) (← links)
• Differentiation of cancer cell origin and molecular subtype by plasma membrane N-glycan profiling. (Q37624209) (← links)
• Long-term survivors among patients with cancer of unknown primary (Q37990226) (← links)
• Overview of various techniques/platforms with critical evaluation of each (Q38163463) (← links)
• Transcriptome Profiling in Human Diseases: New Advances and Perspectives (Q38652049) (← links)
• Detection of cancer cells using triplex DNA molecular beacons based on expression of enhanced green fluorescent protein (eGFP). (Q38976463) (← links)
• Cost-effectiveness of using a gene expression profiling test to aid in identifying the primary tumour in patients with cancer of unknown primary (Q39885004) (← links)
• The epidemiology of metastases in neuroendocrine tumors (Q40610317) (← links)
• Identification and survival outcomes of a cohort of patients with cancer of unknown primary in Ontario, Canada. (Q41136401) (← links)
• Site‐specific cancer deaths in cancer of unknown primary diagnosed with lymph node metastasis may reveal hidden primaries (Q44606549) (← links)
• The challenge of attributing causality in cancer of unknown primary (Q44670742) (← links)
• Global microRNA profiling in favorable prognosis subgroups of cancer of unknown primary (CUP) demonstrates no significant expression differences with metastases of matched known primary tumors (Q46046685) (← links)
• Site-specific survival rates for cancer of unknown primary according to location of metastases (Q46282023) (← links)
• SEOM clinical guideline on unknown primary cancer (2017). (Q48136792) (← links)
• Prognostic impact of presumed breast or ovarian cancer among patients with unfavorable-subset cancer of unknown primary site (Q49578351) (← links)
• Diagnostic work-up of carcinoma of unknown primary: from immunohistochemistry to molecular profiling. (Q51320597) (← links)
• Cell-free DNA in cancer: current insights (Q58113203) (← links)
• Molecular Diagnostics in Clinical Oncology (Q58700723) (← links)
• Survival outcome differences based on treatments used and knowledge of the primary tumour site for patients with cancer of unknown and known primary in Ontario (Q59135396) (← links)
• The Potential Clinical and Economic Value of Primary Tumour Identification in Metastatic Cancer of Unknown Primary Tumour: A Population-Based Retrospective Matched Cohort Study (Q59523028) (← links)
• Molecular characterisation and liquid biomarkers in Carcinoma of Unknown Primary (CUP): taking the ‘U’ out of ‘CUP’ (Q63366116) (← links)
• Gene expression array analysis to determine tissue of origin of carcinoma of unknown primary: cutting edge or already obsolete? (Q84882921) (← links)
• A Neural Network Framework for Predicting the Tissue-of-Origin of 15 Common Cancer Types Based on RNA-Seq Data (Q98771548) (← links)